1. Home
  2. ICL vs AXSM Comparison

ICL vs AXSM Comparison

Compare ICL & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ICL Group Ltd.

ICL

ICL Group Ltd.

N/A

Current Price

$4.14

Market Cap

7.3B

Sector

Industrials

ML Signal

N/A

Logo Axsome Therapeutics Inc.

AXSM

Axsome Therapeutics Inc.

N/A

Current Price

$135.63

Market Cap

7.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ICL
AXSM
Founded
1968
2012
Country
Israel
United States
Employees
N/A
N/A
Industry
Agricultural Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.3B
7.5B
IPO Year
2001
2015

Fundamental Metrics

Financial Performance
Metric
ICL
AXSM
Price
$4.14
$135.63
Analyst Decision
Hold
Strong Buy
Analyst Count
4
22
Target Price
$5.74
★ $264.62
AVG Volume (30 Days)
★ 2.1M
1.0M
Earning Date
11-10-2026
11-02-2026
Dividend Yield
★ 4.72%
N/A
EPS Growth
N/A
★ 38.56
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$10.83
$49.25
Revenue Next Year
$3.48
$52.08
P/E Ratio
$31.41
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.10
$123.00
52 Week High
$6.97
$260.19

Technical Indicators

Market Signals
Indicator
ICL
AXSM
Relative Strength Index (RSI) 25.23 36.23
Support Level N/A $123.00
Resistance Level $5.79 $151.31
Average True Range (ATR) 0.12 6.95
MACD -0.03 1.34
Stochastic Oscillator 4.58 41.86

Price Performance

Historical Comparison
ICL
AXSM

About ICL ICL Group Ltd.

ICL Group Ltd is a manufacturer of products based on minerals. The firm is comprised of four segments: phosphate solutions, potash, industrial products, and growing solutions. These segments all contribute to the company's development of agriculture, food, and engineered material products and services. Maximum revenue is generated from its phosphate solutions segment which uses phosphate commodity products, such as phosphate rock and fertilizer-grade phosphoric acid (green phosphoric acid), to produce specialty products. This segment also produces and markets phosphate-based fertilizers. Geographically, the company generates revenue from Brazil, the United States of America, China, United Kingdom, Germany, Spain, Israel, France, India, Netherlands, and other countries.

About AXSM Axsome Therapeutics Inc.

Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.

Share on Social Networks: